Evidence map›Paper›PMID 35510077›Full record

ArticleProstate international2022

Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description.

Tae Il Noh, Jong Hyun Tae, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Jeong Gu Lee, Sung Gu Kang

Abstract read
In one paragraph

Article in Prostate international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tae Il NohDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Jong Hyun TaeDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Ji Sung ShimDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Seok Ho KangDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Jun CheonDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Jeong Gu LeeDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Sung Gu KangDepartment of Urology, Anam Hospital, Korea University College of Medicine, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the implementation of da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA), we described our initial experience with the da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA) for single-port robotic-assisted radical prostatectomy (SP-RARP). Methods: This retrospective review included 30 consecutive patients with prostate biopsy-confirmed prostate cancer who underwent SP-RARP by a single surgeon between June and November 2020. SP-RARP was performed with a single-incision plus one method, in which the multichannel guide port was inserted directly with an additional assist port. We report our initial experience of perioperative and early functional outcomes. Results: The mean operative time (SD), console time (SD), and blood loss were 142.8 (15.1) min, 109.9 (15.7) min, and 133.0 (72.9) mL, respectively. No intraoperative complications or blood transfusions were reported. Of the 30 patients, 21 (70.0%), 7 (23.3%) and 2 (6.7%) had stage pT2, pT3a and pT3b disease, respectively. Positive surgical margins were reported in 5 of the 30 (16.7%) patients in the final pathology report, including 2 of 21 (9.5%) with stage pT2 and 3 of 9 (33.3%) with ≥ pT3. At 12 weeks after SP-RARP, 80.0% of patients had achieved continence and the potency was 46.7%; 8 of 11 (72.7%) had sexual health inventory for men (SHIM) scores ≥ 17 and 6 of 19 (31.6%) had SHIM scores < 17. Conclusions: The SP platform for radical prostatectomy was technically safe and feasible. After overcoming the technical learning curve, this platform may provide high-quality outcomes comparable to those of multi-port platforms.

Indexed as

da Vinci Single PortEBL, estimated blood lossEPE, extraprostatic extensionFDA, Food and Drug AdministrationGrGP, grade groupGS, Gleason scoreMP-RARP, multiport robot-assisted radical prostatectomyMRI, magnetic resonance imagingNVB, neurovascular bundlePCa, prostate cancerProstate cancerPSA, prostate-specific antigenPSM, positive surgical marginR-LESS, robotic laparoendoscopic single-site surgeryRobotic-assisted radical prostatectomyRP, radical prostatectomySD, standard deviationSHIM, sexual health inventory for menSP-RARP, single-port robotic-assisted radical prostatectomyUS, ultrasound

Identifiers

PMID35510077
PMCPMC9034298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.